Immuno-suppressive agents

Details Immuno-suppressive agents Immuno-suppressive agents

1976-08-10

1977-11-15

Moyer, Donald B.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

424195, 424312, 424318, A61K 940, A61K 3578, A61K 3123, A61K 3120

Patent

active

040585948

ABSTRACT:
A method of providing an immuno-suppressive effect in the control or prophylaxis of neurological disorders, such as multiple sclerosis, and in organ and tissue transplants comprising administering a daily dosage of 5mg to 3g of .gamma.-linolenic or dihomo-.gamma.-linolenic acid or a functional derivative thereof, optionally together with a daily dosage of 25mg to 3g of linoleic acid or a functional derivative thereof. An oil extract from seeds of Oenothera biennis L. is a convenient source of .gamma.-linolenic acid and linoleic acid.

REFERENCES:
E. F. Steinmetz, "Codex Vegelabilis", item 768.
Millar et al, British Medical Journal, Mar. 31, 1973, pp. 765-768.
Field et al, British Medical Journal, Dec. 22, 1973, one page.
The Lancet, Nov. 10, 1973 p. 1080.

Affiliated with

Also associated with

Rating

Immuno-suppressive agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immuno-suppressive agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immuno-suppressive agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1720220